| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Frederick Berro Rivera, Marianne Katharina Taliño, Marie Francesca Ansay, Gerard Francis Mangubat, Mer Lorraine Mahilum, Rajiv Hans Menghrajani, Siena Placino, Sung Whoy Cha, John Paul Aparece, Marc Gregory Yu, Michael Lawrenz Co, Edgar Lerma, Krishnaswami Vijayaraghavan, Peter A McCulloug. Cardiovascular Effects of Excess Growth Hormone: How Real is the Threat? Reviews in cardiovascular medicine. vol 24. issue 4. 2024-07-31. PMID:39076279. |
hf in acromegaly usually presents with biventricular enlargement and diastolic dysfunction and is strongly associated with the duration of gh excess rather than the degree of hormone elevation. |
2024-07-31 |
2024-08-02 |
Not clear |
| Xia Zhang, Heng Wang, Kai Zhang, Jin Ma, Huijing He, Shuang Song, Enhua Shao, Bo Chen, Jingyuan Yang, Xinyu Zhao, Wenda Sui, Meng Wang, Sihua Liu, Xiaopeng Guo, Huijuan Zhu, Yong Yao, Yong Zhong, Bing Xin. Blood Glucose Levels Moderate the Associations Between IGF-1 Levels and Choroidal Metrics in Patients With Diabetes With Acromegaly Without Diabetic Retinopathy. Translational vision science & technology. vol 13. issue 7. 2024-07-30. PMID:39078643. |
to examine the effects of serum growth hormone (gh) and insulin-like growth factor-1 (igf-1) on choroidal structures with different blood glucose levels in patients with diabetes mellitus (dm) with acromegaly without diabetic retinopathy. |
2024-07-30 |
2024-08-02 |
Not clear |
| Ivana Kraljevic, Mirsala Solak, Diana Kovac, Tanja Skoric Polovina, Karin Zibar Tomsic, Annemarie Balasko, Tina Dusek, Darko Kastela. Early postoperative growth hormone measurement as a predictive marker for acromegaly remission. Journal of neuroendocrinology. 2024-07-26. PMID:39056158. |
this study assesses the predictive value of early postoperative gh levels for 3-month and >1-year remission of acromegaly. |
2024-07-26 |
2024-07-28 |
Not clear |
| Ivana Kraljevic, Mirsala Solak, Diana Kovac, Tanja Skoric Polovina, Karin Zibar Tomsic, Annemarie Balasko, Tina Dusek, Darko Kastela. Early postoperative growth hormone measurement as a predictive marker for acromegaly remission. Journal of neuroendocrinology. 2024-07-26. PMID:39056158. |
the 3-month and >1-year remission of acromegaly was defined as achieving the gh nadir of <0.4 μg/l during an oral glucose tolerance test and maintaining normal insulin-like growth factor 1 levels at the initial follow-up visit 3 months after surgery and throughout at least the first year postoperation. |
2024-07-26 |
2024-07-28 |
Not clear |
| Ivana Kraljevic, Mirsala Solak, Diana Kovac, Tanja Skoric Polovina, Karin Zibar Tomsic, Annemarie Balasko, Tina Dusek, Darko Kastela. Early postoperative growth hormone measurement as a predictive marker for acromegaly remission. Journal of neuroendocrinology. 2024-07-26. PMID:39056158. |
receiver-operating characteristic analysis revealed a significant value of fifth-day postoperative gh levels regarding the prediction of 3-month (area under the curve [auc], 0.834; p < .0001) and >1-year (auc, 0.783; p < .0001) acromegaly remission. |
2024-07-26 |
2024-07-28 |
Not clear |
| Ivana Kraljevic, Mirsala Solak, Diana Kovac, Tanja Skoric Polovina, Karin Zibar Tomsic, Annemarie Balasko, Tina Dusek, Darko Kastela. Early postoperative growth hormone measurement as a predictive marker for acromegaly remission. Journal of neuroendocrinology. 2024-07-26. PMID:39056158. |
notably, all patients with fifth-day postoperative gh levels ≤0.23 μg/l exhibited remission of acromegaly throughout the follow-up period. |
2024-07-26 |
2024-07-28 |
Not clear |
| Ivana Kraljevic, Mirsala Solak, Diana Kovac, Tanja Skoric Polovina, Karin Zibar Tomsic, Annemarie Balasko, Tina Dusek, Darko Kastela. Early postoperative growth hormone measurement as a predictive marker for acromegaly remission. Journal of neuroendocrinology. 2024-07-26. PMID:39056158. |
early postoperative gh measurement could be a reliable predictor of both 3-month and >1-year remission of acromegaly. |
2024-07-26 |
2024-07-28 |
Not clear |
| Tongxin Xiao, Xinxin Mao, Ou Wang, Yong Yao, Kan Deng, Huijuan Zhu, Lian Dua. Suspected silent pituitary somatotroph neuroendocrine tumor associated with acromegaly-like bone disorders: a case report. BMC endocrine disorders. vol 24. issue 1. 2024-07-24. PMID:39044175. |
growth hormone (gh) positive pituitary neuroendocrine tumors do not always cause acromegaly. |
2024-07-24 |
2024-07-26 |
Not clear |
| Chan Woo Kang, Ju Hun Oh, Eun Kyung Wang, Yaru Bao, Ye Bin Kim, Min-Ho Lee, Yang Jong Lee, Young Seok Jo, Cheol Ryong Ku, Eun Jig Le. Excess endocrine growth hormone in acromegaly promotes the aggressiveness and metastasis of triple-negative breast cancer. iScience. vol 27. issue 7. 2024-07-16. PMID:39006481. |
herein, we used an acromegaly mouse model to investigate the role of excess endocrine gh on triple-negative breast cancer (tnbc) growth and metastasis. |
2024-07-16 |
2024-07-18 |
mouse |
| Nahali Haver, Reut Halperin, Yossi Bar-On, Liana Tripto-Shkolnik, Muhamad Badarne, Amit Tiros. Serum phosphate levels at diagnosis predict long-term risk for hypopituitarism in patients with acromegaly. Hormones (Athens, Greece). 2024-07-06. PMID:38970757. |
excess growth hormone (gh) secretion in acromegaly has a major impact on mineral balance and serum phosphate levels. |
2024-07-06 |
2024-07-12 |
Not clear |
| Yuto Mitsui, Kosuke Mukai, Michio Otsuki, Satoru Oshino, Youichi Saitoh, Masaharu Kohara, Eiichi Morii, Atsunori Fukuhara, Iichiro Shimomur. Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly. Pituitary. 2024-07-02. PMID:38954291. |
we previously showed the clinical characteristics of acromegaly with a paradoxical growth hormone (gh) response to oral glucose or thyrotropin-releasing hormone. |
2024-07-02 |
2024-07-06 |
Not clear |
| Yuto Mitsui, Kosuke Mukai, Michio Otsuki, Satoru Oshino, Youichi Saitoh, Masaharu Kohara, Eiichi Morii, Atsunori Fukuhara, Iichiro Shimomur. Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly. Pituitary. 2024-07-02. PMID:38954291. |
however, the clinical characteristics of acromegaly with an increased gh response to luteinizing hormone-releasing hormone (lhrh responders) remain unclear. |
2024-07-02 |
2024-07-06 |
Not clear |
| Amy X Guo, Asha Job, Donato Pacione, Nidhi Agrawa. Risk of intracranial meningioma in patients with acromegaly: a systematic review. Frontiers in endocrinology. vol 15. 2024-06-26. PMID:38919490. |
acromegaly is a rare endocrine disorder caused by hypersecretion of growth hormone (gh) from a pituitary adenoma. |
2024-06-26 |
2024-06-29 |
Not clear |
| Amy X Guo, Asha Job, Donato Pacione, Nidhi Agrawa. Risk of intracranial meningioma in patients with acromegaly: a systematic review. Frontiers in endocrinology. vol 15. 2024-06-26. PMID:38919490. |
to the best of our knowledge, a systematic review examining the association between meningiomas and elevated gh levels (due to gh-secreting adenomas in acromegaly or exposure to exogenous gh) has never been conducted. |
2024-06-26 |
2024-06-29 |
Not clear |
| Mariana Lopes-Pinto, Patrícia Lunet Marques, Ema Lacerda-Nobre, Diego Miceli, Rodolfo Oliveira Leal, Pedro Marque. Acromegaly in humans and cats: Pathophysiological, clinical and management resemblances and differences. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. vol 76. 2024-06-15. PMID:38810595. |
acromegaly is a disorder associated with excessive levels of growth hormone (gh) and insulin-like growth factor-1 (igf-1). |
2024-06-15 |
2024-06-18 |
Not clear |
| Marco Losa, Enrico Garbin, Riccardo Calcagnile, Giacomo Voltan, Filippo Ceccato, Carla Scaroni, Gianluca Occhi, Pietro Mortin. The Preoperative Paradoxical GH Response to Oral Glucose Load Predicts a low Risk of Recurrence in Acromegaly. The Journal of clinical endocrinology and metabolism. 2024-06-15. PMID:38878276. |
the preoperative paradoxical gh response to oral glucose load predicts a low risk of recurrence in acromegaly. |
2024-06-15 |
2024-06-18 |
Not clear |
| Marco Losa, Enrico Garbin, Riccardo Calcagnile, Giacomo Voltan, Filippo Ceccato, Carla Scaroni, Gianluca Occhi, Pietro Mortin. The Preoperative Paradoxical GH Response to Oral Glucose Load Predicts a low Risk of Recurrence in Acromegaly. The Journal of clinical endocrinology and metabolism. 2024-06-15. PMID:38878276. |
a paradoxical growth hormone (gh) response to oral glucose load (ogtt) in acromegaly is associated with a milder phenotype. |
2024-06-15 |
2024-06-18 |
Not clear |
| Flávia Pereira, Mariana Cebotari, Inês Camelo, Lígia Coelh. Addressing Acromegaly-Related Malocclusion With Surgery-First Orthognathic Surgery: A Clinical Case Report. Cureus. vol 16. issue 6. 2024-06-10. PMID:38855491. |
acromegaly is a dysfunction caused by the excessive production of growth hormone (gh), which leads to systemic changes and orofacial manifestations. |
2024-06-10 |
2024-06-14 |
Not clear |
| Flávia Pereira, Mariana Cebotari, Inês Camelo, Lígia Coelh. Addressing Acromegaly-Related Malocclusion With Surgery-First Orthognathic Surgery: A Clinical Case Report. Cureus. vol 16. issue 6. 2024-06-10. PMID:38855491. |
in acromegaly caused by a pituitary adenoma, which secretes an excessive amount of gh, disproportionate mandibular growth may occur, leading to skeletal class iii malocclusion in adulthood. |
2024-06-10 |
2024-06-14 |
Not clear |
| Emanuele Varaldo, Nunzia Prencipe, Alessandro Maria Berton, Luigi Simone Aversa, Fabio Bioletto, Raffaele De Marco, Valentina Gasco, Francesco Zenga, Silvia Grottol. Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery. Pituitary. 2024-06-07. PMID:38847919. |
our study aimed to assess changes in postoperative fluid balance in acromegaly patients and correlate them with both copeptin and growth hormone (gh) levels. |
2024-06-07 |
2024-06-10 |
Not clear |